"Market-shaping efforts led by global partners working with the private sector are delivering important price reductions in key TB commodities, making lifesaving tools more accessible and affordable."
We are proud to be one such partner reducing prices of 3HP and pretomanid.
Did you miss out on the remarkable story of The Black Angels by @MariaSmilios and the incredible insights of our partners from @TBAlliance during our webinar? Dont' worry, we got you... We recorded the whole webinar just for you! 👇 https://t.co/J5vTQltw7o
Our next webinar is both timely and timeless! @TBAlliance and @MariaSmilios will share stories of TB drug development past, present, and future. Don’t miss it! Register here ➡️ https://t.co/5GuKnXImkq #EndTB#6MonthsMax
All people should have access to new, shorter, and more effective treatments for drug-resistant tuberculosis. But, right now that is not the case. Fast Track the Cure is working to change that!
Join our community to stay connected 👉 https://t.co/l8vQAAlWWU #6MonthsMax
In December 2024, pretomanid and #6MonthsMax treatments received regulatory approval in China. Work with national stakeholders including the China Anti-Tuberculosis Association, to ensure rapid roll-out of the regimen continues. Read more https://t.co/2347H9SRKz
The National TB Programme, a local partner, and TB Alliance developed a national implementation plan. By November 2024,5,000+ individuals had been enrolled on the treatments and 90%+ of all individuals eligible for these regimens are now receiving them. https://t.co/2347H9SRKz
We @TBAlliance acknowledge and thank Australia for its generous support and partnership as we continue to develop shorter and more effective treatment regimens to fight #tuberculosis#TB#EndTB#globalhealth
Attending the #UnionConf2024? Great! We are inviting you to a Lunch and Learn this Friday! Learn more about how communities #FastTracktheCure for DR-TB in their country. #6MonthsMax
As an endorsing partner of the @FastTrackTBCure initiative, we were pleased to attend a session at the #UnionConf on how shorter, all-oral treatments for drug resistant tuberculosis are now available. Now we need rapid & equitable rollout of new regimens! #6MonthsMax
H.E. @BudiGSadikin encourages the TB community to greater emphasise the urgency required to #EndTB.
Minister Budi also wants to see innovation that makes TB elimination cheaper and more accessible, with shorter treatment regimens and less drugs.
We are excited to be in partnership with the Government of Indonesia for the High Level Meeting on TB Innovation. Minister of Health @BudiGSadikin kicks off with an inspiring address — and asks the TB community to get more driven to reach #endTB goals
#UnionConf2024
@WHO notes in latest report that #TB is world’s largest infectious disease killer - together we can do more to improve diagnostics, introduce vaccines and continue work to improve #access to improved treatment #tuberculosis#EndTB https://t.co/ydAkCYx5ni
🆕 #Tuberculosis, also known as TB, resurged as the leading infectious disease killer in 2023.
Approximately 8.2 million people were newly diagnosed with #TB in 2023 – the highest number recorded since WHO began global TB monitoring in 1995 https://t.co/77FMSBRmkr
Turns out we can save lives and money. When countries use the short, all-oral regimens to treat people with drug-resistant TB, they save between 15-60%: https://t.co/0aBOafRIyG #6MonthsMax@TBAlliance@TBpeoplePH@tbpeople_ukr